Drug intelligence / Profile preview

hydrocodone + acetaminophen + fentanyl

Development stage
Unknown
Lead developer
Janssen Pharmaceutica
Modality
Small Molecules
Administration
Oral, Transdermal, Buccal, Sublingual, Intravenous
01

Overview

This is a combination drug consisting of **hydrocodone**, **acetaminophen**, and **fentanyl**. All three components are used for pain management, particularly in cases of severe pain. - **Hydrocodone** is an opioid analgesic and antitussive agent that acts mainly as a mu-opioid receptor agonist in the central nervous system, leading to inhibition of ascending pain pathways, alteration of pain perception, and suppression of the cough reflex. - **Acetaminophen** (also known as paracetamol) is a non-opioid analgesic and antipyretic that works primarily by inhibiting prostaglandin synthesis in the central nervous system, thereby reducing pain and fever. - **Fentanyl** is a highly potent synthetic opioid agonist, acting primarily on mu-opioid receptors. It provides rapid and strong analgesia suitable for breakthrough or persistent severe pain. This specific triple-drug combination is *not currently available as an approved pharmaceutical product* according to the search results. However, all three drugs are individually approved and frequently used in pain management, with hydrocodone/acetaminophen combinations being especially common for moderate-to-severe pain and fentanyl reserved for severe pain requiring strong opioids[1][2][3][5]. Combining all three is generally not standard clinical practice due to the risk of additive central nervous system and respiratory depression, as well as increased potential for abuse, overdose, and serious side effects.

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on hydrocodone + acetaminophen + fentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocodone + acetaminophen + fentanyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call